Ede Migh

HUN-REN Szegedi Biológiai Kutatóközpont — Hungary

Medicine · Health Sciences

12h-index1.2kcitations47works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(13), Cancer, Lipids, and Metabolism(13), Cancer, Hypoxia, and Metabolism(10), Cellular Mechanics and Interactions(9), Cell Image Analysis Techniques(8)

Publications47 total

Intrahepatic reporter assay reveals leaky somatic blockade of L1 retrotransposition in mice
2026Open Access
Prevalent Gut Phages Encode Modular Adhesins Mediating Epithelial Binding and Endoplasmic Reticulum Trafficking
2026Open Access
Microenvironmental information significantly improves the recognition of cell types in human lung cancer patients
2025Open Access
A Morpho-Proteomic Atlas of Mitosis at Sub-Minute Resolution
2025· 1 citedOpen Access
Deep visual multi-omics profiling reveals mechanisms that underlie cancer cell differentiation and aggressiveness in clear cell renal cell carcinoma
2025
SuperCUT, an unsupervised multimodal image registration with deep learning for biomedical microscopy
Briefings in Bioinformatics·2024· 2 citedOpen Access
Chloroplast phosphate transporter CrPHT4-7 regulates phosphate homeostasis and photosynthesis in Chlamydomonas
PLANT PHYSIOLOGY·2023· 11 citedOpen Access
Mitochondrial and immune response dysregulation in melanoma recurrence
Clinical and Translational Medicine·2023· 11 citedOpen Access
The chloroplastic phosphate transporter CrPHT4-7 supports phosphate homeostasis and photosynthesis in Chlamydomonas
2023Open Access
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2
Cell Reports Methods·2023· 7 citedOpen Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Péter Horváth(31), Ábel Szkalisity(17), Mária Kovács(15), Elina Ikonen(14), Jeovanis Gil(14), Melinda Rezeli(14), Johan Malm(14), György Marko‐Varga(14), Juho Pirhonen(13), Jaana Hagström(13), Yonghyo Kim(13), Maarit Hölttä‐Vuori(13), Johan Peränen(13), Hanna Seppänen(13), Caj Haglund(13), Pauli Puolakkainen(13), András Kriston(12), Ferenc Kovács(11), József Mihály(10), Réka Hollandi(8)